CNB Bank’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663 | Hold |
8
| – | – | ﹤0.01% | 477 |
|
|
2025
Q1 | $649 | Hold |
8
| – | – | ﹤0.01% | 466 |
|
|
2024
Q4 | $720 | Sell |
8
-8
| -50% | -$720 | ﹤0.01% | 472 |
|
|
2024
Q3 | $1.58K | Hold |
16
| – | – | ﹤0.01% | 485 |
|
|
2024
Q2 | $1.48K | Hold |
16
| – | – | ﹤0.01% | 484 |
|
|
2024
Q1 | $1.52K | Sell |
16
-299
| -95% | -$28.4K | ﹤0.01% | 469 |
|
|
2023
Q4 | $28.1K | Hold |
315
| – | – | 0.02% | 293 |
|
|
2023
Q3 | $23K | Hold |
315
| – | – | 0.01% | 299 |
|
|
2023
Q2 | $26.2K | Hold |
315
| – | – | 0.02% | 267 |
|
|
2023
Q1 | $24K | Sell |
315
-9
| -3% | -$686 | 0.01% | 281 |
|
|
2022
Q4 | $26.9K | Sell |
324
-14
| -4% | -$1.16K | 0.02% | 261 |
|
|
2022
Q3 | $27K | Hold |
338
| – | – | 0.02% | 258 |
|
|
2022
Q2 | $25K | Hold |
338
| – | – | 0.02% | 259 |
|
|
2022
Q1 | $30K | Sell |
338
-17
| -5% | -$1.51K | 0.02% | 256 |
|
|
2021
Q4 | $40K | Sell |
355
-1,163
| -77% | -$131K | 0.02% | 238 |
|
|
2021
Q3 | $191K | Buy |
1,518
+293
| +24% | +$36.9K | 0.11% | 150 |
|
|
2021
Q2 | $166K | Buy |
1,225
+139
| +13% | +$18.8K | 0.1% | 160 |
|
|
2021
Q1 | $147K | Buy |
1,086
+385
| +55% | +$52.1K | 0.1% | 165 |
|
|
2020
Q4 | $99K | Buy |
701
+126
| +22% | +$17.8K | 0.07% | 172 |
|
|
2020
Q3 | $64K | Buy |
575
+296
| +106% | +$32.9K | 0.05% | 197 |
|
|
2020
Q2 | $31K | Buy |
+279
| New | +$31K | 0.03% | 240 |
|